亨廷顿病的神经炎症:原因,后果和治疗策略
Alina Blusch1, Maria Björkqvist1
1Wallenberg Neuroscience Center, Brain Disease Biomarker Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.
Journal of Huntington's disease
|August 7, 2025
概括
亨廷顿病 (HD) 涉及影响大脑和身体的炎症. 了解HD中的免疫系统作用为神经炎症和神经退行提供了新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 遗传学 遗传学 是一个
背景情况:
- 亨廷顿病 (HD) 是一种进展性神经退行性疾病.
- 中枢和外围的神经炎症在HD进展中越来越多地涉及到.
- 在HD患者的血液和脑脊液中观察到改变的炎症标志物和免疫细胞群.
研究的目的:
- 审查免疫激活在亨廷顿病病理学中的重要性.
- 讨论突变的亨廷丁在免疫细胞和中央免疫系统的改变中的作用.
- 探索针对针对性免疫调节的治疗策略,以治疗疾病.
主要方法:
- 审查现有的神经组织学和神经成像研究.
- 对HD患者血液和脑脊液研究结果的分析.
- 综合证据关于本质性和中央免疫效应在HD.
主要成果:
- 神经炎症过程是HD病理生理学的组成部分.
- 突变的亨廷丁对免疫细胞有内在的影响.
- 中央和外周免疫变化都会导致HD中神经炎症和神经退行.
结论:
- 免疫激活在亨廷顿病中起着至关重要的作用.
- 了解神经免疫相互作用是开发新型治疗方法的关键.
- 免疫调节策略有可能通过减少神经炎症和退行来治疗HD.
更多相关视频
10:52Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System
Published on: December 10, 2021
2.6K
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
6.3K
相关概念视频
Parkinson's Disease: Overview
708
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
708
Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
Alzheimer's Disease: Treatment
262
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
262
Neural Regulation
40.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.0K
Alzheimer's Disease: Overview
669
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
669
Biological Causes of Schizophrenia
149
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
149
